Eberl A, Qadri S, Saavalainen P, Sipponen T, et al. Higher serum infliximab concentrations during induction predict short-term endoscopic response in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2022;34:1125-1131.
PMID: 36170681